Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-18-003618)

Filing Details

Accession Number:: 0001683168-18-003618
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-06 08:02:37
Reporting Period:: 2018-12-03

Accepted Time:: 2018-12-06 08:02:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1355790	International Stem Cell Corp	ISCO.OB	Pharmaceutical Preparations (2834)	204494098

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1446397	Russell Kern	C/O International Stem Cell Corporation 5950 Priestly Drive Carlsbad CA 92008	Evp And Cso	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-03	1,800	$1.09	180,198	No	4	M	Direct
Common Stock	Disposition	2018-12-03	1,800	$1.67	178,398	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-12-03	1,800	$0.00	90,000	$1.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
88,200		2027-02-10	No	4	M	Direct

Footnotes

The reported shares were sold in open market transactions through a broker-dealer at $1.67 per share.
The option, representing a total of 90,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.